GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Geron Corporation securities during the specified Class Period, indicating potential legal issues for the company related to misleading statements about its revenue outlook and product performance [1][5]. Group 1: Class Action Details - The class action is filed for securities purchased between June 7, 2024, and February 25, 2025, and investors may be entitled to compensation without upfront costs through a contingency fee arrangement [1][2]. - Interested parties can join the class action by contacting Rosen Law Firm, with a deadline to serve as lead plaintiff set for May 12, 2025 [3][6]. Group 2: Allegations Against Geron Corporation - The lawsuit alleges that Geron Corporation made false and misleading statements regarding its product Rytelo, creating an inaccurate perception of its market potential and revenue growth while downplaying risks associated with seasonality and competition [5]. - The claims suggest that the actual market performance of Rytelo was significantly below expectations, with challenges in market penetration and competition impacting patient starts more than previously indicated [5].